Aurobindo Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?
AUROBINDO has four hundred and ninety-two approved drugs.
There are nineteen tentative approvals on AUROBINDO drugs.
Summary for Aurobindo
US Patents: | 0 |
Tradenames: | 372 |
Ingredients: | 346 |
NDAs: | 492 |
Patent Litigation for Aurobindo: | See patent lawsuits for Aurobindo |
PTAB Cases with Aurobindo as petitioner: | See PTAB cases with Aurobindo as petitioner |
Drugs and US Patents for Aurobindo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | CLOBETASOL PROPIONATE | clobetasol propionate | CREAM;TOPICAL | 075338-001 | Feb 9, 2001 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma | SIMPESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 206851-001 | Apr 7, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 206286-001 | Feb 5, 2019 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Usa | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 090649-003 | Jun 21, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.